sg001
Showing 1 - 9 of 9
Advanced Solid Tumor Trial in Beijing (Simmitinib, SG001)
Not yet recruiting
- Advanced Solid Tumor
- Simmitinib
- SG001
-
Beijing, Beijing, ChinaCancer Hospital,Chinese Academy of Medical Sciences and Peking U
Nov 9, 2023
Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)
Not yet recruiting
- Metastatic Colorectal Cancer (mCRC)
- JMT101
- +3 more
- (no location specified)
Oct 13, 2023
Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),
Not yet recruiting
- Locally Advanced Unresectable Esophageal Squamous Carcinoma
- Docetaxel for Injection (Albumin-bound)
- +4 more
-
Jinan, Shandong, China
- +1 more
Nov 16, 2023
Uterine Cervical Cancer Trial in Beijing (SG001)
Recruiting
- Uterine Cervical Cancer
- SG001
-
Beijing, ChinaNational Cancer Center/Cancer Hospital,Chinese Academy of Medica
Nov 14, 2021
Triple Negative Breast Cancer Trial in Guangzhou (SG001, Nab-paclitaxel)
Recruiting
- Triple Negative Breast Cancer
- SG001
- Nab-paclitaxel
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Oct 13, 2021
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (SG001, Doxorubicin HCl liposome injection)
Not yet recruiting
- Epithelial Ovarian Cancer
- +2 more
- SG001
- Doxorubicin hydrochloride liposome injection
- (no location specified)
Jul 20, 2021
Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan
Not yet recruiting
- Advanced Biliary Tract Cancer
- +3 more
- Irinotecan Liposome Injection
- +3 more
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Sep 16, 2021
Advanced Solid Tumours, Cervical Cancer, Malignant Mesothelioma Trial in Shanghai (SG001)
Recruiting
- Advanced Solid Tumours
- +4 more
- SG001
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Apr 29, 2021